Postprandial SPARC

There is 1 paper on postprandial SPARC in aging research: 1 trial in people.

Biomarker

1 paper studies it7 findings

See all 1 papers on postprandial SPARC

“individuals with higher baseline SPARC-1H levels were associated with fewer improvements in fasting insulin (β ± SE: 1.54 ± 0.43; P = 0.002), fasting glucose (0.10 ± 0.04; P = 0.049), the homeostasis model assessment of insulin resistance (HOMA-IR, 0.47 ± 0.12; P = 0.0005)”
Predictive value of 1-hour postprandial SPARC levels on metabolic outcomes from Mediterranean diet adherence: results from a randomized controlled feeding studyLife metabolism2025doi:10.1093/lifemeta/loaf039
  • Human trial1

Interventions

1

Mediterranean diet

downin humans1

1 study
  1. Mediterranean diet decreases postprandial SPARC in humans after 6-month calorie restriction.

    “Intriguingly, only in the MD group, plasma SPARC-1H levels decreased significantly after 3-month (P = 0.009) and 6-month (P = 0.028) CR, while no significant changes of SPARC-1H levels were found in the TJD or CD group.”

    Human trialafter 6-month calorie restriction6 monthsn = 81

    Predictive value of 1-hour postprandial SPARC levels on metabolic outcomes from Mediterranean diet adherence: results from a randomized controlled feeding study

    Life metabolism

More on Mediterranean diet

Associations

3

Fasting glucose

upin humans1

1 study
  1. Postprandial SPARC predicts fasting glucose in the Mediterranean diet group from baseline to 6 months.

    “baseline SPARC-1H levels were positively associated with the changes in HOMA-IR (P = 0.0005), HOMA-β (P = 0.047), fasting insulin (P = 0.002), and fasting glucose (P = 0.049) from baseline to 6 months, specifically in the MD group”

    Human trialin the Mediterranean diet group from baseline to 6 months6 monthsn = 81

    Predictive value of 1-hour postprandial SPARC levels on metabolic outcomes from Mediterranean diet adherence: results from a randomized controlled feeding study

    Life metabolism

  2. Postprandial SPARC predicts fasting glucose in Mediterranean diet group (β = 0.10 ± 0.04, P = 0.049).

    “fasting glucose (0.10 ± 0.04; P = 0.049)”

    Human trialin Mediterranean diet groupplasma6 months

    Predictive value of 1-hour postprandial SPARC levels on metabolic outcomes from Mediterranean diet adherence: results from a randomized controlled feeding study

    Life metabolism

More on Fasting glucose

Fasting insulin

upin humans1

1 study
  1. Postprandial SPARC predicts fasting insulin in the Mediterranean diet group from baseline to 6 months.

    “baseline SPARC-1H levels were positively associated with the changes in HOMA-IR (P = 0.0005), HOMA-β (P = 0.047), fasting insulin (P = 0.002), and fasting glucose (P = 0.049) from baseline to 6 months, specifically in the MD group”

    Human trialin the Mediterranean diet group from baseline to 6 months6 monthsn = 81

    Predictive value of 1-hour postprandial SPARC levels on metabolic outcomes from Mediterranean diet adherence: results from a randomized controlled feeding study

    Life metabolism

  2. Postprandial SPARC predicts fasting insulin in Mediterranean diet group (β = 1.54 ± 0.43, P = 0.002).

    “individuals with higher baseline SPARC-1H levels were associated with fewer improvements in fasting insulin (β ± SE: 1.54 ± 0.43; P = 0.002)”

    Human trialin Mediterranean diet groupplasma6 months

    Predictive value of 1-hour postprandial SPARC levels on metabolic outcomes from Mediterranean diet adherence: results from a randomized controlled feeding study

    Life metabolism

More on Fasting insulin

HOMA-IR

upin humans1

1 study
  1. Postprandial SPARC predicts HOMA-IR in the Mediterranean diet group from baseline to 6 months.

    “baseline SPARC-1H levels were positively associated with the changes in HOMA-IR (P = 0.0005), HOMA-β (P = 0.047), fasting insulin (P = 0.002), and fasting glucose (P = 0.049) from baseline to 6 months, specifically in the MD group”

    Human trialin the Mediterranean diet group from baseline to 6 months6 monthsn = 81

    Predictive value of 1-hour postprandial SPARC levels on metabolic outcomes from Mediterranean diet adherence: results from a randomized controlled feeding study

    Life metabolism

  2. Postprandial SPARC predicts HOMA-IR in Mediterranean diet group (β = 0.47 ± 0.12, P = 0.0005).

    “individuals with higher baseline SPARC-1H levels were associated with fewer improvements in fasting insulin (β ± SE: 1.54 ± 0.43; P = 0.002), fasting glucose (0.10 ± 0.04; P = 0.049), the homeostasis model assessment of insulin resistance (HOMA-IR, 0.47 ± 0.12; P = 0.0005)”

    Human trialin Mediterranean diet groupplasma6 months

    Predictive value of 1-hour postprandial SPARC levels on metabolic outcomes from Mediterranean diet adherence: results from a randomized controlled feeding study

    Life metabolism

More on HOMA-IR

Latest